{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:35:51Z","timestamp":1777502151054,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Loss and absence of melanocytes due to a number of factors is responsible for vitiligo; known to be the commonest disorder of pigmentation.  The aim of the study was to assess clinically and dermoscopically the efficacy of topical trichloroacetic acid 70% versus methoxsalen 0.2% paint in stable acral vitiligo. The patients were randomly divided into 2 groups. Group a (<jats:italic>n<\/jats:italic>\u2009=\u200935) received topical 0.2% methoxsalen every other day for 4 months duration with dermoscopic follow up while group b (<jats:italic>n<\/jats:italic>\u2009=\u200935) received received topical TCA 70% application at the clinic every two weeks for 4 months with dermoscopic follow up. The majority of subjects in both groups experienced either no or mild improvement. In TCA group, mean improvement was 4.0\u2009\u00b1\u200911.6% with range of 0\u201360% while in the methoxsalen group, mean improvement was 0.57\u2009\u00b1\u20093.3% with range of 0\u201320% (<jats:italic>p<\/jats:italic>\u2009=\u20090.051). The majority of patients reported poor satisfaction. Both modalities did not demonstrate a significant clinical nor dermoscopic response. TCA 70% had a lower effective rate than other studies probably due to resistance of acral vitiliginous lesions to treatment in comparison to other sites of the body. Further larger multi centre studies with different concentration and combination modalities are required to detect promising treatments for vitligo.<\/jats:p>","DOI":"10.1038\/s41598-025-88811-w","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T12:27:10Z","timestamp":1739017630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and dermoscopic assessment of the efficacy of topical trichloroacetic acid 70% versus methoxsalen 0.2% paint in stable acral vitiligo"],"prefix":"10.1038","volume":"15","author":[{"given":"Ahmed R.","family":"Elshahed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr M.","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-5241","authenticated-orcid":false,"given":"Mohamed L.","family":"Elsaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"issue":"7","key":"88811_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00403-024-03054-5","volume":"316","author":"MS Zaky","year":"2024","unstructured":"Zaky, M. S., Atallah, R. B., El Abasy, N. T. A. & Elsaie, M. L. Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo. Arch. Dermatol. Res. 316(7), 350 (2024).","journal-title":"Arch. Dermatol. Res."},{"issue":"6","key":"88811_CR2","doi-asserted-by":"publisher","first-page":"e13998","DOI":"10.1111\/dth.13998","volume":"33","author":"AM Zaki","year":"2020","unstructured":"Zaki, A. M. et al. Therapeutic implications of assessment of serum zinc levels in patients with vitiligo: a patient controlled prospective study. Dermatol. Ther. 33(6), e13998. https:\/\/doi.org\/10.1111\/dth.13998 (2020).","journal-title":"Dermatol. Ther."},{"issue":"4","key":"88811_CR3","first-page":"359","volume":"14","author":"HM El Hassab","year":"2015","unstructured":"El Hassab, H. M. et al. Study of human leukocyte antigen-cw in Egyptian patients with vitiligo. J. Drugs Dermatol. 14(4), 359\u2013364 (2015).","journal-title":"J. Drugs Dermatol."},{"issue":"2","key":"88811_CR4","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1097\/DSS.0000000000002736","volume":"47","author":"A Nofal","year":"2021","unstructured":"Nofal, A., Fawzy, M. M. & Alakad, R. Trichloroacetic acid in different concentrations: a promising treatment modality for Vitiligo. Dermatol. Surg. 47(2), e53\u2013e57 (2021).","journal-title":"Dermatol. Surg."},{"issue":"4","key":"88811_CR5","doi-asserted-by":"publisher","first-page":"e13532","DOI":"10.1111\/dth.13532","volume":"33","author":"M Khater","year":"2020","unstructured":"Khater, M., Nasr, M., Salah, S. & Khattab, F. M. Clinical evaluation of the efficacy of trichloroacetic acid 70% after microneedling vs intradermal injection of 5-fluorouracil in the treatment of nonsegmental vitiligo; a prospective comparative study. Dermatol. Ther. 33(4), e13532 (2020).","journal-title":"Dermatol. Ther."},{"key":"88811_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.7241\/ourd.20123.42","volume":"3","author":"N Puri","year":"2012","unstructured":"Puri, N. & Puri, A. A comparative study on 100% TCA versus 88% phenol for the treatment of vitiligo. Our Dermatol. 3, 184\u2013186 (2012).","journal-title":"Our Dermatol."},{"key":"88811_CR7","first-page":"959","volume":"84","author":"N Hunter","year":"2016","unstructured":"Hunter, N., Mashaly, H., Dorgham, D. & Ismail, S. Trichloroacetic acid peel 15% + NB-UVB versus trichloroacetic acid peel 25% + NB-UVB for stable non-segmental vitiligo. Med. J. Cairo Univ. 84, 959\u2013963 (2016).","journal-title":"Med. J. Cairo Univ."},{"key":"88811_CR8","doi-asserted-by":"crossref","unstructured":"El Mofty, M. et al. Effect of different types of therapeutic trauma on vitiligo lesions. Dermatol. Ther. ;30, 2 (2017).","DOI":"10.1111\/dth.12447"},{"issue":"5","key":"88811_CR9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/DSS.0000000000001699","volume":"45","author":"TM Razmi","year":"2019","unstructured":"Razmi, T. M., Kumaran, S. M. & Parsad, D. Trichloroacetic acid 25% Peel to facilitate dermabrasion at difficult sites in Vitiligo surgery. Dermatol. Surg. 45(5), 750\u2013752 (2019).","journal-title":"Dermatol. Surg."},{"issue":"11","key":"88811_CR10","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.4103\/ijo.IJO_413_17","volume":"65","author":"A Maitray","year":"2017","unstructured":"Maitray, A. & Rishi, P. Methoxsalen-induced macular toxicity. Indian J. Ophthalmol. 65(11), 1243\u20131245 (2017).","journal-title":"Indian J. Ophthalmol."},{"key":"88811_CR11","first-page":"142","volume":"23","author":"AP Dhotre","year":"2020","unstructured":"Dhotre, A. P., Singh, S. P., Madke, B., Singh, A. & Jawade, S. A comparison of the efficacy of 50% trichloroacetic acid (TCA) application and dermabrasion in patients with idiopathic guttate hypomelanosis (IGH): a pilot study. Iran. J. Dermatol. 23, 142\u2013149 (2020).","journal-title":"Iran. J. Dermatol."},{"key":"88811_CR12","doi-asserted-by":"crossref","unstructured":"Mukhtar, M. Trichloroacetic acid cautery for repigmenting nonresponsive vitiligo on lips. J. Cutan. Aesthet. Surg.  16(2), 154\u2013155 (2023).","DOI":"10.4103\/JCAS.JCAS_131_22"},{"issue":"3","key":"88811_CR13","doi-asserted-by":"publisher","first-page":"e15294","DOI":"10.1111\/dth.15294","volume":"35","author":"A Nofal","year":"2022","unstructured":"Nofal, A., Eldeeb, F., Shalaby, M. & Al-Balat, W. Microneedling combined with pimecrolimus, 5-fluorouracil, and trichloroacetic acid in the treatment of vitiligo: a comparative study. Dermatol. Ther. 35(3), e15294 (2022).","journal-title":"Dermatol. Ther."},{"key":"88811_CR14","doi-asserted-by":"publisher","first-page":"1294919","DOI":"10.3389\/fimmu.2023.1294919","volume":"14","author":"X Wang","year":"2024","unstructured":"Wang, X., Wu, W., Chen, J., Li, C. & Li, S. Management of the refractory vitiligo patient: current therapeutic strategies and future options. Front. Immunol. 14, 1294919. https:\/\/doi.org\/10.3389\/fimmu.2023.1294919 (2024).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88811-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88811-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T12:27:16Z","timestamp":1739017636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88811-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88811"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88811-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study protocol was reviewed and approved by ethics committee on human research by Al Azhar faculty of medicine (No. 00000078). All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consents were received from participants or their guardians upon explanation of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable, the manuscript does not contain any individual personal data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Written consent for publication"}}],"article-number":"4756"}}